Tools and applications in synthetic biology

Advanced Drug Delivery Reviews

Volumn 105, Issue , 2016, Pages 20-34

  MacDonald, I Cody ^a   Deans, Tara L ^a  

^a Department of Electrical and Computer Engineering   (United States)

Author keywords

Cell therapy; Gene networks; Genetic circuits; Synthetic biology

Indexed keywords

APPLICATION PROGRAMS; CYTOLOGY; GENE EXPRESSION; GENE THERAPY; MAMMALS; MOLECULAR BIOLOGY;

BIOLOGICAL BEHAVIOR; CELL THERAPY; CELLULAR ENGINEERING; GENE NETWORKS; GENETIC CIRCUITS; SYNTHETIC BIOLOGY; THERAPEUTIC APPLICATION; TOOLS AND APPLICATIONS;

CELL ENGINEERING;

MESSENGER RNA; TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASE; ZINC FINGER NUCLEASE;

BASE PAIRING; BINDING SITE; BIOSENSOR; BIOTECHNOLOGY; CELL ENGINEERING; CELL FREE SYSTEM; CELL INTERACTION; CRISPR CAS SYSTEM; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETIC ENGINEERING; HUMAN; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; REVIEW; RIBOSOME BINDING SITE; SIGNAL TRANSDUCTION; SYNTHETIC BIOLOGY; SYNTHETIC ENZYME PATHWAY; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; ANIMAL; GENE REGULATORY NETWORK; PROCEDURES;

ANIMALS; GENE REGULATORY NETWORKS; HUMANS; SYNTHETIC BIOLOGY;

EID: 84991063112     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2016.08.008     Document Type: Review

References (199)

1. [1] Callura, J.M., Cantor, C.R., Collins, J.J., Genetic switchboard for synthetic biology applications. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 5850–5855.
2. [2] Nandagopal, N., Elowitz, M.B., Synthetic biology: integrated gene circuits. Science 333 (2011), 1244–1248.
3. [3] Sprinzak, D., Elowitz, M.B., Reconstruction of genetic circuits. Nature 438 (2005), 443–448.
4. [4] Guet, C.C., Elowitz, M.B., Hsing, W., Leibler, S., Combinatorial synthesis of genetic networks. Science 296 (2002), 1466–1470.
5. [5] Elowitz, M., Lim, W.A., Build life to understand it. Nature 468 (2010), 889–890.
6. [6] Bashor, C.J., Horwitz, A.A., Peisajovich, S.G., Lim, W.A., Rewiring cells: synthetic biology as a tool to interrogate the organizational principles of living systems. Annu. Rev. Biophys. 39 (2010), 515–537.
7. [7] Guido, N.J., Wang, X., Adalsteinsson, D., McMillen, D., Hasty, J., Cantor, C.R., Elston, T.C., Collins, J.J., A bottom-up approach to gene regulation. Nature 439 (2006), 856–860.
8. [8] Bowsher, C.G., Swain, P.S., Environmental sensing, information transfer, and cellular decision-making. Curr. Opin. Biotechnol. 28C (2014), 149–155.
9. [9] Deans, T.L., Elisseeff, J.H., The life of a cell: probing the complex relationships with the world. Cell Stem Cell 6 (2010), 499–501.
10. [10] Lienert, F., Lohmueller, J.J., Garg, A., Silver, P.A., Synthetic biology in mammalian cells: next generation research tools and therapeutics. Nat. Rev. Mol. Cell Biol. 15 (2014), 95–107.
11. [11] Anesiadis, N., Kobayashi, H., Cluett, W.R., Mahadevan, R., Analysis and design of a genetic circuit for dynamic metabolic engineering. ACS Synth. Biol. 2 (2013), 442–452.
12. [12] Basu, S., Gerchman, Y., Collins, C.H., Arnold, F.H., Weiss, R., A synthetic multicellular system for programmed pattern formation. Nature 434 (2005), 1130–1134.
13. [13] Basu, S., Mehreja, R., Thiberge, S., Chen, M.T., Weiss, R., Spatiotemporal control of gene expression with pulse-generating networks. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 6355–6360.
14. [14] Bulter, T., Lee, S.G., Wong, W.W., Fung, E., Connor, M.R., Liao, J.C., Design of artificial cell–cell communication using gene and metabolic networks. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 2299–2304.
15. [15] Callura, J.M., Dwyer, D.J., Isaacs, F.J., Cantor, C.R., Collins, J.J., Tracking, tuning, and terminating microbial physiology using synthetic riboregulators. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 15898–15903.
16. [16] Chen, A.Y., Deng, Z., Billings, A.N., Seker, U.O., Lu, M.Y., Citorik, R.J., Zakeri, B., Lu, T.K., Synthesis and patterning of tunable multiscale materials with engineered cells. Nat. Mater. 13 (2014), 515–523.
17. [17] Chen, Y.Y., Jensen, M.C., Smolke, C.D., Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 8531–8536.
18. [18] Chen, Y.Y., Smolke, C.D., From DNA to targeted therapeutics: bringing synthetic biology to the clinic. Sci. Transl. Med., 3, 2011 (106 ps142).
19. [19] Culler, S.J., Hoff, K.G., Smolke, C.D., Reprogramming cellular behavior with RNA controllers responsive to endogenous proteins. Science 330 (2010), 1251–1255.
20. [20] Dahl, R.H., Zhang, F., Alonso-Gutierrez, J., Baidoo, E., Batth, T.S., Redding-Johanson, A.M., Petzold, C.J., Mukhopadhyay, A., Lee, T.S., Adams, P.D., Keasling, J.D., Engineering dynamic pathway regulation using stress-response promoters. Nat. Biotechnol. 31 (2013), 1039–1046.
21. [21] Danino, T., Mondragon-Palomino, O., Tsimring, L., Hasty, J., A synchronized quorum of genetic clocks. Nature 463 (2010), 326–330.
22. [22] Ham, T.S., Lee, S.K., Keasling, J.D., Arkin, A.P., Design and construction of a double inversion recombination switch for heritable sequential genetic memory. PLoS One, 3, 2008, e2815.
23. [23] Deans, T.L., Parallel networks: synthetic biology and artificial intelligence. ACM J. Emerg. Technol., 11, 2014.
24. [24] Ajo-Franklin, C.M., Drubin, D.A., Eskin, J.A., Gee, E.P., Landgraf, D., Phillips, I., Silver, P.A., Rational design of memory in eukaryotic cells. Genes Dev. 21 (2007), 2271–2276.
25. [25] Burrill, D.R., Inniss, M.C., Boyle, P.M., Silver, P.A., Synthetic memory circuits for tracking human cell fate. Genes Dev. 26 (2012), 1486–1497.
26. [26] Burrill, D.R., Silver, P.A., Making cellular memories. Cell 140 (2010), 13–18.
27. [27] Purcell, O., Lu, T.K., Synthetic analog and digital circuits for cellular computation and memory. Curr. Opin. Biotechnol. 29C (2014), 146–155.
28. [28] Siuti, P., Yazbek, J., Lu, T.K., Synthetic circuits integrating logic and memory in living cells. Nat. Biotechnol. 31 (2013), 448–452.
29. [29] Yang, L., Nielsen, A.A., Fernandez-Rodriguez, J., McClune, C.J., Laub, M.T., Lu, T.K., Voigt, C.A., Permanent genetic memory with > 1-byte capacity. Nat. Methods 11 (2014), 1261–1266.
30. [30] Deans, T.L., Cantor, C.R., Collins, J.J., A tunable genetic switch based on RNAi and repressor proteins for regulating gene expression in mammalian cells. Cell 130 (2007), 363–372.
31. [31] Bonnet, J., Yin, P., Ortiz, M.E., Subsoontorn, P., Endy, D., Amplifying genetic logic gates. Science 340 (2013), 599–603.
32. [32] Slusarczyk, A.L., Lin, A., Weiss, R., Foundations for the design and implementation of synthetic genetic circuits. Nat. Rev. Genet. 13 (2012), 406–420.
33. [33] Cronin, C.A., Gluba, W., Scrable, H., The lac operator-repressor system is functional in the mouse. Genes Dev. 15 (2001), 1506–1517.
34. [34] Liu, H.S., Lee, C.H., Lee, C.F., Su, I.J., Chang, T.Y., Lac/Tet dual-inducible system functions in mammalian cell lines. Biotechniques 24 (1998), 624–628 (630-622).
35. [35] Gardner, T.S., Cantor, C.R., Collins, J.J., Construction of a genetic toggle switch in Escherichia coli. Nature 403 (2000), 339–342.
36. [36] Greber, D., El-Baba, M.D., Fussenegger, M., Intronically encoded siRNAs improve dynamic range of mammalian gene regulation systems and toggle switch. Nucleic Acids Res., 36, 2008, e101.
37. [37] Ellis, T., Wang, X., Collins, J.J., Diversity-based, model-guided construction of synthetic gene networks with predicted functions. Nat. Biotechnol. 27 (2009), 465–471.
38. [38] Wu, M., Su, R.Q., Li, X., Ellis, T., Lai, Y.C., Wang, X., Engineering of regulated stochastic cell fate determination. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 10610–10615.
39. [39] Elowitz, M.B., Leibler, S., A synthetic oscillatory network of transcriptional regulators. Nature 403 (2000), 335–338.
40. [40] Fung, E., Wong, W.W., Suen, J.K., Bulter, T., Lee, S.G., Liao, J.C., A synthetic gene-metabolic oscillator. Nature 435 (2005), 118–122.
41. [41] Judd, E.M., Laub, M.T., McAdams, H.H., Toggles and oscillators: new genetic circuit designs. BioEssays 22 (2000), 507–509.
42. [42] Tigges, M., Marquez-Lago, T.T., Stelling, J., Fussenegger, M., A tunable synthetic mammalian oscillator. Nature 457 (2009), 309–312.
43. [43] Miyamoto, T., Razavi, S., DeRose, R., Inoue, T., Synthesizing biomolecule-based Boolean logic gates. ACS Synth. Biol. 2 (2013), 72–82.
44. [44] Payne, S., Li, B., Cao, Y., Schaeffer, D., Ryser, M.D., You, L., Temporal control of self-organized pattern formation without morphogen gradients in bacteria. Mol. Syst. Biol., 9, 2013, 697.
45. [45] Kobayashi, H., Kaern, M., Araki, M., Chung, K., Gardner, T.S., Cantor, C.R., Collins, J.J., Programmable cells: interfacing natural and engineered gene networks. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 8414–8419.
46. [46] Weber, W., Fussenegger, M., Molecular diversity–the toolbox for synthetic gene switches and networks. Curr. Opin. Chem. Biol. 15 (2011), 414–420.
47. [47] Horner, M., Reischmann, N., Weber, W., Synthetic biology: programming cells for biomedical applications. Perspect. Biol. Med. 55 (2012), 490–502.
48. [48] Karlsson, M., Weber, W., Therapeutic synthetic gene networks. Curr. Opin. Biotechnol. 23 (2012), 703–711.
49. [49] Weber, W., Fussenegger, M., Emerging biomedical applications of synthetic biology. Nat. Rev. Genet. 13 (2012), 21–35.
50. [50] Ye, H., Fussenegger, M., Synthetic therapeutic gene circuits in mammalian cells. FEBS Lett. 588 (2014), 2537–2544.
51. [51] Litcofsky, K.D., Afeyan, R.B., Krom, R.J., Khalil, A.S., Collins, J.J., Iterative plug-and-play methodology for constructing and modifying synthetic gene networks. Nat. Methods 9 (2012), 1077–1080.
52. [52] Schwille, P., Bottom-up synthetic biology: engineering in a tinkerer's world. Science 333 (2011), 1252–1254.
53. [53] Wu, F., Menn, D.J., Wang, X., Quorum-sensing crosstalk-driven synthetic circuits: from unimodality to trimodality. Chem. Biol. 21 (2014), 1629–1638.
54. [54] Diao, J., Charlebois, D.A., Nevozhay, D., Bodi, Z., Pal, C., Balazsi, G., Efflux pump control alters synthetic gene circuit function. ACS Synth. Biol., 2016.
55. [55] Kim, T., Folcher, M., Doaud-El Baba, M., Fussenegger, M., A synthetic erectile optogenetic stimulator enabling blue-light-inducible penile erection. Angew. Chem. Int. Ed. Engl. 54 (2015), 5933–5938.
56. [56] Cheng, A.A., Lu, T.K., Synthetic biology: an emerging engineering discipline. Annu. Rev. Biomed. Eng. 14 (2012), 155–178.
57. [57] Ryu, M.H., Gomelsky, M., Near-infrared light responsive synthetic c-di-GMP module for optogenetic applications. ACS Synth. Biol. 3 (2014), 802–810.
58. [58] Tyszkiewicz, A.B., Muir, T.W., Activation of protein splicing with light in yeast. Nat. Methods 5 (2008), 303–305.
59. [59] Tischer, D., Weiner, O.D., Illuminating cell signalling with optogenetic tools. Nat. Rev. Mol. Cell Biol. 15 (2014), 551–558.
60. [60] Toettcher, J.E., Gong, D., Lim, W.A., Weiner, O.D., Light-based feedback for controlling intracellular signaling dynamics. Nat. Methods 8 (2011), 837–839.
61. [61] Yazawa, M., Sadaghiani, A.M., Hsueh, B., Dolmetsch, R.E., Induction of protein–protein interactions in live cells using light. Nat. Biotechnol. 27 (2009), 941–945.
62. [62] Kennedy, M.J., Hughes, R.M., Peteya, L.A., Schwartz, J.W., Ehlers, M.D., Tucker, C.L., Rapid blue-light-mediated induction of protein interactions in living cells. Nat. Methods 7 (2010), 973–975.
63. [63] Muller, K., Weber, W., Optogenetic tools for mammalian systems. Mol. BioSyst. 9 (2013), 596–608.
64. [64] Muller, K., Zurbriggen, M.D., Weber, W., An optogenetic upgrade for the Tet-OFF system. Biotechnol. Bioeng. 112 (2015), 1483–1487.
65. [65] Gardner, L., Deiters, A., Light-controlled synthetic gene circuits. Curr. Opin. Chem. Biol. 16 (2012), 292–299.
66. [66] Schmidl, S.R., Sheth, R.U., Wu, A., Tabor, J.J., Refactoring and optimization of light-switchable Escherichia coli two-component systems. ACS Synth. Biol. 3 (2014), 820–831.
67. [67] Levskaya, A., Chevalier, A.A., Tabor, J.J., Simpson, Z.B., Lavery, L.A., Levy, M., Davidson, E.A., Scouras, A., Ellington, A.D., Marcotte, E.M., Voigt, C.A., Synthetic biology: engineering Escherichia coli to see light. Nature 438 (2005), 441–442.
68. [68] Olson, E.J., Tabor, J.J., Optogenetic characterization methods overcome key challenges in synthetic and systems biology. Nat. Chem. Biol. 10 (2014), 502–511.
69. [69] Konermann, S., Brigham, M.D., Trevino, A.E., Hsu, P.D., Heidenreich, M., Cong, L., Platt, R.J., Scott, D.A., Church, G.M., Zhang, F., Optical control of mammalian endogenous transcription and epigenetic states. Nature 500 (2013), 472–476.
70. [70] Ye, H., Daoud-El Baba, M., Peng, R.W., Fussenegger, M., A synthetic optogenetic transcription device enhances blood-glucose homeostasis in mice. Science 332 (2011), 1565–1568.
71. [71] Khalil, A.S., Lu, T.K., Bashor, C.J., Ramirez, C.L., Pyenson, N.C., Joung, J.K., Collins, J.J., A synthetic biology framework for programming eukaryotic transcription functions. Cell 150 (2012), 647–658.
72. [72] Rao, C.V., Expanding the synthetic biology toolbox: engineering orthogonal regulators of gene expression. Curr. Opin. Biotechnol. 23 (2012), 689–694.
73. [73] Grover, A., Pande, A., Choudhary, K., Gupta, K., Sundar, D., Re-programming DNA-binding specificity in zinc finger proteins for targeting unique address in a genome. Syst. Synth. Biol. 4 (2010), 323–329.
74. [74] Jamieson, A.C., Miller, J.C., Pabo, C.O., Drug discovery with engineered zinc-finger proteins. Nat. Rev. Drug Discov. 2 (2003), 361–368.
75. [75] Garg, A., Lohmueller, J.J., Silver, P.A., Armel, T.Z., Engineering synthetic TAL effectors with orthogonal target sites. Nucleic Acids Res. 40 (2012), 7584–7595.
76. [76] Perez-Pinera, P., Ousterout, D.G., Brunger, J.M., Farin, A.M., Glass, K.A., Guilak, F., Crawford, G.E., Hartemink, A.J., Gersbach, C.A., Synergistic and tunable human gene activation by combinations of synthetic transcription factors. Nat. Methods 10 (2013), 239–242.
77. [77] Qi, L.S., Larson, M.H., Gilbert, L.A., Doudna, J.A., Weissman, J.S., Arkin, A.P., Lim, W.A., Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152 (2013), 1173–1183.
78. [78] Mali, P., Yang, L., Esvelt, K.M., Aach, J., Guell, M., DiCarlo, J.E., Norville, J.E., Church, G.M., RNA-guided human genome engineering via Cas9. Science 339 (2013), 823–826.
79. [79] Farzadfard, F., Perli, S.D., Lu, T.K., Tunable and multifunctional eukaryotic transcription factors based on CRISPR/Cas. ACS Synth. Biol. 2 (2013), 604–613.
80. [80] Nissim, L., Perli, S.D., Fridkin, A., Perez-Pinera, P., Lu, T.K., Multiplexed and programmable regulation of gene networks with an integrated RNA and CRISPR/Cas toolkit in human cells. Mol. Cell 54 (2014), 698–710.
81. [81] Gilbert, L.A., Larson, M.H., Morsut, L., Liu, Z., Brar, G.A., Torres, S.E., Stern-Ginossar, N., Brandman, O., Whitehead, E.H., Doudna, J.A., Lim, W.A., Weissman, J.S., Qi, L.S., CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154 (2013), 442–451.
82. [82] Chavez, A., Scheiman, J., Vora, S., Pruitt, B.W., Tuttle, M., P.R.I. E, Lin, S., Kiani, S., Guzman, C.D., Wiegand, D.J., Ter-Ovanesyan, D., Braff, J.L., Davidsohn, N., Housden, B.E., Perrimon, N., Weiss, R., Aach, J., Collins, J.J., Church, G.M., Highly efficient Cas9-mediated transcriptional programming. Nat. Methods 12 (2015), 326–328.
83. [83] Kiani, S., Chavez, A., Tuttle, M., Hall, R.N., Chari, R., Ter-Ovanesyan, D., Qian, J., Pruitt, B.W., Beal, J., Vora, S., Buchthal, J., Kowal, E.J., Ebrahimkhani, M.R., Collins, J.J., Weiss, R., Church, G., Cas9 gRNA engineering for genome editing, activation and repression. Nat. Methods 12 (2015), 1051–1054.
84. [84] Esvelt, K.M., Mali, P., Braff, J.L., Moosburner, M., Yaung, S.J., Church, G.M., Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat. Methods 10 (2013), 1116–1121.
85. [85] Lu, T.K., Khalil, A.S., Collins, J.J., Next-generation synthetic gene networks. Nat. Biotechnol. 27 (2009), 1139–1150.
86. [86] Capecchi, M.R., Altering the genome by homologous recombination. Science 244 (1989), 1288–1292.
87. [87] Capecchi, M.R., The new mouse genetics: altering the genome by gene targeting. Trends Genet. 5 (1989), 70–76.
88. [88] Thomas, K.R., Capecchi, M.R., Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51 (1987), 503–512.
89. [89] Urnov, F.D., Rebar, E.J., Holmes, M.C., Zhang, H.S., Gregory, P.D., Genome editing with engineered zinc finger nucleases. Nat. Rev. Genet. 11 (2010), 636–646.
90. [90] Joung, J.K., Sander, J.D., TALENs: a widely applicable technology for targeted genome editing. Nat. Rev. Mol. Cell Biol. 14 (2013), 49–55.
91. [91] Miller, J.C., Tan, S., Qiao, G., Barlow, K.A., Wang, J., Xia, D.F., Meng, X., Paschon, D.E., Leung, E., Hinkley, S.J., Dulay, G.P., Hua, K.L., Ankoudinova, I., Cost, G.J., Urnov, F.D., Zhang, H.S., Holmes, M.C., Zhang, L., Gregory, P.D., Rebar, E.J., A TALE nuclease architecture for efficient genome editing. Nat. Biotechnol. 29 (2011), 143–148.
92. [92] Perez-Pinera, P., Ousterout, D.G., Gersbach, C.A., Advances in targeted genome editing. Curr. Opin. Chem. Biol. 16 (2012), 268–277.
93. [93] Gaj, T., Gersbach, C.A., Barbas, C.F. III, ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol. 31 (2013), 397–405.
94. [94] Hu, J.H., Davis, K.M., Liu, D.R., Chemical biology approaches to genome editing: understanding, controlling, and delivering programmable nucleases. Cell Chem. Biol. 23 (2016), 57–73.
95. [95] Price, A.A., Sampson, T.R., Ratner, H.K., Grakoui, A., Weiss, D.S., Cas9-mediated targeting of viral RNA in eukaryotic cells. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 6164–6169.
96. [96] Hsu, P.D., Scott, D.A., Weinstein, J.A., Ran, F.A., Konermann, S., Agarwala, V., Li, Y., Fine, E.J., Wu, X., Shalem, O., Cradick, T.J., Marraffini, L.A., Bao, G., Zhang, F., DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31 (2013), 827–832.
97. [97] Sander, J.D., Joung, J.K., CRISPR-Cas systems for editing, regulating and targeting genomes. Nat. Biotechnol. 32 (2014), 347–355.
98. [98] Makarova, K.S., Haft, D.H., Barrangou, R., Brouns, S.J., Charpentier, E., Horvath, P., Moineau, S., Mojica, F.J., Wolf, Y.I., Yakunin, A.F., van der Oost, J., Koonin, E.V., Evolution and classification of the CRISPR-Cas systems. Nat. Rev. Microbiol. 9 (2011), 467–477.
99. [99] Mali, P., Esvelt, K.M., Church, G.M., Cas9 as a versatile tool for engineering biology. Nat. Methods 10 (2013), 957–963.
100. [100] Hsu, P.D., Lander, E.S., Zhang, F., Development and applications of CRISPR-Cas9 for genome engineering. Cell 157 (2014), 1262–1278.
101. [101] Maeder, M.L., Gersbach, C.A., Genome-editing technologies for gene and cell therapy. Mol. Ther., 2016.
102. [102] Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J.A., Charpentier, E., A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337 (2012), 816–821.
103. [103] Mougiakos, I., Bosma, E.F., de Vos, W.M., van Kranenburg, R., van der Oost, J., Next generation prokaryotic engineering: the CRISPR-Cas toolkit. Trends Biotechnol. 34 (2016), 575–587.
104. [104] Standage-Beier, K., Zhang, Q., Wang, X., Targeted large-scale deletion of bacterial genomes using CRISPR-Nickases. ACS Synth. Biol. 4 (2015), 1217–1225.
105. [105] Gonzalez, F., Zhu, Z., Shi, Z.D., Lelli, K., Verma, N., Li, Q.V., Huangfu, D., An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells. Cell Stem Cell 15 (2014), 215–226.
106. [106] Aubrey, B.J., Kelly, G.L., Kueh, A.J., Brennan, M.S., O'Connor, L., Milla, L., Wilcox, S., Tai, L., Strasser, A., Herold, M.J., An inducible lentiviral guide RNA platform enables the identification of tumor-essential genes and tumor-promoting mutations in vivo. Cell Rep. 10 (2015), 1422–1432.
107. [107] Dow, L.E., Fisher, J., O'Rourke, K.P., Muley, A., Kastenhuber, E.R., Livshits, G., Tschaharganeh, D.F., Socci, N.D., Lowe, S.W., Inducible in vivo genome editing with CRISPR-Cas9. Nat. Biotechnol. 33 (2015), 390–394.
108. [108] Zetsche, B., Volz, S.E., Zhang, F., A split-Cas9 architecture for inducible genome editing and transcription modulation. Nat. Biotechnol. 33 (2015), 139–142.
109. [109] Kiani, S., Beal, J., Ebrahimkhani, M.R., Huh, J., Hall, R.N., Xie, Z., Li, Y., Weiss, R., CRISPR transcriptional repression devices and layered circuits in mammalian cells. Nat. Methods 11 (2014), 723–726.
110. [110] Zalatan, J.G., Lee, M.E., Almeida, R., Gilbert, L.A., Whitehead, E.H., La Russa, M., Tsai, J.C., Weissman, J.S., Dueber, J.E., Qi, L.S., Lim, W.A., Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds. Cell 160 (2015), 339–350.
111. [111] Galdzicki, M., Clancy, K.P., Oberortner, E., Pocock, M., Quinn, J.Y., Rodriguez, C.A., Roehner, N., Wilson, M.L., Adam, L., Anderson, J.C., Bartley, B.A., Beal, J., Chandran, D., Chen, J., Densmore, D., Endy, D., Grunberg, R., Hallinan, J., Hillson, N.J., Johnson, J.D., Kuchinsky, A., Lux, M., Misirli, G., Peccoud, J., Plahar, H.A., Sirin, E., Stan, G.B., Villalobos, A., Wipat, A., Gennari, J.H., Myers, C.J., Sauro, H.M., The synthetic biology open language (SBOL) provides a community standard for communicating designs in synthetic biology. Nat. Biotechnol. 32 (2014), 545–550.
112. [112] Galdzicki, M., Rodriguez, C., Chandran, D., Sauro, H.M., Gennari, J.H., Standard biological parts knowledgebase. PLoS One, 6, 2011, e17005.
113. [113] Roehner, N., Myers, C.J., A methodology to annotate systems biology markup language models with the synthetic biology open language. ACS Synth. Biol. 3 (2014), 57–66.
114. [114] Roehner, N., Oberortner, E., Pocock, M., Beal, J., Clancy, K., Madsen, C., Misirli, G., Wipat, A., Sauro, H., Myers, C.J., Proposed data model for the next version of the synthetic biology open language. ACS Synth. Biol. 4 (2015), 57–71.
115. [115] Roehner, N., Zhang, Z., Nguyen, T., Myers, C.J., Generating systems biology markup language models from the synthetic biology open language. ACS Synth. Biol. 4 (2015), 873–879.
116. [116] Tamsir, A., Tabor, J.J., Voigt, C.A., Robust multicellular computing using genetically encoded NOR gates and chemical ‘wires’. Nature 469 (2011), 212–215.
117. [117] Farzadfard, F., Lu, T.K., Synthetic biology. Genomically encoded analog memory with precise in vivo DNA writing in living cell populations. Science, 346, 2014 (1256272).
118. [118] Friedland, A.E., Lu, T.K., Wang, X., Shi, D., Church, G., Collins, J.J., Synthetic gene networks that count. Science 324 (2009), 1199–1202.
119. [119] Hemphill, J., Deiters, A., DNA computation in mammalian cells: microRNA logic operations. J. Am. Chem. Soc. 135 (2013), 10512–10518.
120. [120] Brophy, J.A., Voigt, C.A., Principles of genetic circuit design. Nat. Methods 11 (2014), 508–520.
121. [121] Daniel, R., Rubens, J.R., Sarpeshkar, R., Lu, T.K., Synthetic analog computation in living cells. Nature 497 (2013), 619–623.
122. [122] Way, J.C., Collins, J.J., Keasling, J.D., Silver, P.A., Integrating biological redesign: where synthetic biology came from and where it needs to go. Cell 157 (2014), 151–161.
123. [123] Auslander, S., Auslander, D., Muller, M., Wieland, M., Fussenegger, M., Programmable single-cell mammalian biocomputers. Nature 487 (2012), 123–127.
124. [124] Becskei, A., Seraphin, B., Serrano, L., Positive feedback in eukaryotic gene networks: cell differentiation by graded to binary response conversion. EMBO J. 20 (2001), 2528–2535.
125. [125] Becskei, A., Serrano, L., Engineering stability in gene networks by autoregulation. Nature 405 (2000), 590–593.
126. [126] Hsu, C., Scherrer, S., Buetti-Dinh, A., Ratna, P., Pizzolato, J., Jaquet, V., Becskei, A., Stochastic signalling rewires the interaction map of a multiple feedback network during yeast evolution. Nat. Commun., 3, 2012, 682.
127. [127] Ingolia, N.T., Murray, A.W., Positive-feedback loops as a flexible biological module. Curr. Biol. 17 (2007), 668–677.
128. [128] Siuti, P., Yazbek, J., Lu, T.K., Engineering genetic circuits that compute and remember. Nat. Protoc. 9 (2014), 1292–1300.
129. [129] Inniss, M.C., Silver, P.A., Building synthetic memory. Curr. Biol. 23 (2013), R812–R816.
130. [130] Gordley, R.M., Gersbach, C.A., Barbas, C.F. III, Synthesis of programmable integrases. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 5053–5058.
131. [131] Isaacs, F.J., Dwyer, D.J., Ding, C., Pervouchine, D.D., Cantor, C.R., Collins, J.J., Engineered riboregulators enable post-transcriptional control of gene expression. Nat. Biotechnol. 22 (2004), 841–847.
132. [132] Auslander, S., Stucheli, P., Rehm, C., Auslander, D., Hartig, J.S., Fussenegger, M., A general design strategy for protein-responsive riboswitches in mammalian cells. Nat. Methods 11 (2014), 1154–1160.
133. [133] Green, A.A., Silver, P.A., Collins, J.J., Yin, P., Toehold switches: de-novo-designed regulators of gene expression. Cell 159 (2014), 925–939.
134. [134] Chan, B.P., Leong, K.W., Scaffolding in tissue engineering: general approaches and tissue-specific considerations. Eur. Spine J. 17:Suppl. 4 (2008), 467–479.
135. [135] Guilak, F., Cohen, D.M., Estes, B.T., Gimble, J.M., Liedtke, W., Chen, C.S., Control of stem cell fate by physical interactions with the extracellular matrix. Cell Stem Cell 5 (2009), 17–26.
136. [136] Engler, A.J., Sen, S., Sweeney, H.L., Discher, D.E., Matrix elasticity directs stem cell lineage specification. Cell 126 (2006), 677–689.
137. [137] Griffith, L.G., Naughton, G., Tissue engineering–current challenges and expanding opportunities. Science 295 (2002), 1009–1014.
138. [138] Hillel, A.T., Unterman, S., Nahas, Z., Reid, B., Coburn, J.M., Axelman, J., Chae, J.J., Guo, Q., Trow, R., Thomas, A., Hou, Z., Lichtsteiner, S., Sutton, D., Matheson, C., Walker, P., David, N., Mori, S., Taube, J.M., Elisseeff, J.H., Photoactivated composite biomaterial for soft tissue restoration in rodents and in humans. Sci. Transl. Med., 3, 2011, 93ra67.
139. [139] Wu, I., Nahas, Z., Kimmerling, K.A., Rosson, G.D., Elisseeff, J.H., An injectable adipose matrix for soft-tissue reconstruction. Plast. Reconstr. Surg. 129 (2012), 1247–1257.
140. [140] Cukierman, E., Pankov, R., Stevens, D.R., Yamada, K.M., Taking cell-matrix adhesions to the third dimension. Science 294 (2001), 1708–1712.
141. [141] Legant, W.R., Miller, J.S., Blakely, B.L., Cohen, D.M., Genin, G.M., Chen, C.S., Measurement of mechanical tractions exerted by cells in three-dimensional matrices. Nat. Methods 7 (2010), 969–971.
142. [142] Gubeli, R.J., Burger, K., Weber, W., Synthetic biology for mammalian cell technology and materials sciences. Biotechnol. Adv. 31 (2013), 68–78.
143. [143] Deans, T.L., Singh, A., Gibson, M., Elisseeff, J.H., Regulating synthetic gene networks in 3D materials. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 15217–15222.
144. [144] Singh, A., Deans, T.L., Elisseeff, J.H., Photomodulation of cellular gene expression in hydrogels. ACS Macro Lett. 2 (2013), 269–272.
145. [145] Dobrin, A., Saxena, P., Fussenegger, M., Synthetic biology: applying biological circuits beyond novel therapies. Integr. Biol. (Camb.), 2015.
146. [146] Kis, Z., Pereira, H.S., Homma, T., Pedrigi, R.M., Krams, R., Mammalian synthetic biology: emerging medical applications. J. R. Soc. Interface, 12, 2015.
147. [147] Khalil, A.S., Collins, J.J., Synthetic biology: applications come of age. Nat. Rev. Genet. 11 (2010), 367–379.
148. [148] Folcher, M., Fussenegger, M., Synthetic biology advancing clinical applications. Curr. Opin. Chem. Biol. 16 (2012), 345–354.
149. [149] Kittleson, J.T., Wu, G.C., Anderson, J.C., Successes and failures in modular genetic engineering. Curr. Opin. Chem. Biol. 16 (2012), 329–336.
150. [150] Slomovic, S., Pardee, K., Collins, J.J., Synthetic biology devices for in vitro and in vivo diagnostics. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 14429–14435.
151. [151] Feng, J., Jester, B.W., Tinberg, C.E., Mandell, D.J., Antunes, M.S., Chari, R., Morey, K.J., Rios, X., Medford, J.I., Church, G.M., Fields, S., Baker, D., A general strategy to construct small molecule biosensors in eukaryotes. Elife, 4, 2015.
152. [152] Saeidi, N., Wong, C.K., Lo, T.M., Nguyen, H.X., Ling, H., Leong, S.S., Poh, C.L., Chang, M.W., Engineering microbes to sense and eradicate Pseudomonas aeruginosa, a human pathogen. Mol. Syst. Biol., 7, 2011, 521.
153. [153] Gaber, R., Lebar, T., Majerle, A., Ster, B., Dobnikar, A., Bencina, M., Jerala, R., Designable DNA-binding domains enable construction of logic circuits in mammalian cells. Nat. Chem. Biol. 10 (2014), 203–208.
154. [154] Kramer, B.P., Viretta, A.U., Daoud-El-Baba, M., Aubel, D., Weber, W., Fussenegger, M., An engineered epigenetic transgene switch in mammalian cells. Nat. Biotechnol. 22 (2004), 867–870.
155. [155] Lin, Y., Sohn, C.H., Dalal, C.K., Cai, L., Elowitz, M.B., Combinatorial gene regulation by modulation of relative pulse timing. Nature 527 (2015), 54–58.
156. [156] Weber, W., Stelling, J., Rimann, M., Keller, B., Daoud-El Baba, M., Weber, C.C., Aubel, D., Fussenegger, M., A synthetic time-delay circuit in mammalian cells and mice. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 2643–2648.
157. [157] Yu, Y.A., Zhang, Q., Szalay, A.A., Establishment and characterization of conditions required for tumor colonization by intravenously delivered bacteria. Biotechnol. Bioeng. 100 (2008), 567–578.
158. [158] Forbes, N.S., Engineering the perfect (bacterial) cancer therapy. Nat. Rev. Cancer 10 (2010), 785–794.
159. [159] Xiang, S., Fruehauf, J., Li, C.J., Short hairpin RNA-expressing bacteria elicit RNA interference in mammals. Nat. Biotechnol. 24 (2006), 697–702.
160. [160] Zhao, M., Yang, M., Li, X.M., Jiang, P., Baranov, E., Li, S., Xu, M., Penman, S., Hoffman, R.M., Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 755–760.
161. [161] Cronin, M., Akin, A.R., Collins, S.A., Meganck, J., Kim, J.B., Baban, C.K., Joyce, S.A., van Dam, G.M., Zhang, N., van Sinderen, D., O'Sullivan, G.C., Kasahara, N., Gahan, C.G., Francis, K.P., Tangney, M., High resolution in vivo bioluminescent imaging for the study of bacterial tumour targeting. PLoS One, 7, 2012, e30940.
162. [162] Danino, T., Prindle, A., Kwong, G.A., Skalak, M., Li, H., Allen, K., Hasty, J., Bhatia, S.N., Programmable probiotics for detection of cancer in urine. Sci. Transl. Med., 7, 2015 (289ra284).
163. [163] Courbet, A., Endy, D., Renard, E., Molina, F., Bonnet, J., Detection of pathological biomarkers in human clinical samples via amplifying genetic switches and logic gates. Sci. Transl. Med., 7, 2015 (289ra283).
164. [164] Nissim, L., Bar-Ziv, R.H., A tunable dual-promoter integrator for targeting of cancer cells. Mol. Syst. Biol., 6, 2010, 444.
165. [165] Xie, Z., Wroblewska, L., Prochazka, L., Weiss, R., Benenson, Y., Multi-input RNAi-based logic circuit for identification of specific cancer cells. Science 333 (2011), 1307–1311.
166. [166] Slomovic, S., Collins, J.J., DNA sense-and-respond protein modules for mammalian cells. Nat. Methods 12 (2015), 1085–1090.
167. [167] Mootz, H.D., Muir, T.W., Protein splicing triggered by a small molecule. J. Am. Chem. Soc. 124 (2002), 9044–9045.
168. [168] Schwartz, E.C., Saez, L., Young, M.W., Muir, T.W., Post-translational enzyme activation in an animal via optimized conditional protein splicing. Nat. Chem. Biol. 3 (2007), 50–54.
169. [169] Kotula, J.W., Kerns, S.J., Shaket, L.A., Siraj, L., Collins, J.J., Way, J.C., Silver, P.A., Programmable bacteria detect and record an environmental signal in the mammalian gut. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 4838–4843.
170. [170] Ptashne, M., Jeffrey, A., Johnson, A.D., Maurer, R., Meyer, B.J., Pabo, C.O., Roberts, T.M., Sauer, R.T., How the lambda repressor and cro work. Cell 19 (1980), 1–11.
171. [171] Zhang, Y.H., Production of biocommodities and bioelectricity by cell-free synthetic enzymatic pathway biotransformations: challenges and opportunities. Biotechnol. Bioeng. 105 (2010), 663–677.
172. [172] Pardee, K., Green, A.A., Takahashi, M.K., Braff, D., Lambert, G., Lee, J.W., Ferrante, T., Ma, D., Donghia, N., Fan, M., Daringer, N.M., Bosch, I., Dudley, D.M., O'Connor, D.H., Gehrke, L., Collins, J.J., Rapid, low-cost detection of Zika virus using programmable biomolecular components. Cell 165 (2016), 1255–1266.
173. [173] Kwon, Y.C., Jewett, M.C., High-throughput preparation methods of crude extract for robust cell-free protein synthesis. Sci. Rep., 5, 2015, 8663.
174. [174] Carlson, E.D., Gan, R., Hodgman, C.E., Jewett, M.C., Cell-free protein synthesis: applications come of age. Biotechnol. Adv. 30 (2012), 1185–1194.
175. [175] Harris, D.C., Jewett, M.C., Cell-free biology: exploiting the interface between synthetic biology and synthetic chemistry. Curr. Opin. Biotechnol. 23 (2012), 672–678.
176. [176] Hodgman, C.E., Jewett, M.C., Cell-free synthetic biology: thinking outside the cell. Metab. Eng. 14 (2012), 261–269.
177. [177] Pardee, K., Green, A.A., Ferrante, T., Cameron, D.E., DaleyKeyser, A., Yin, P., Collins, J.J., Paper-based synthetic gene networks. Cell 159 (2014), 940–954.
178. [178] Shimizu, Y., Inoue, A., Tomari, Y., Suzuki, T., Yokogawa, T., Nishikawa, K., Ueda, T., Cell-free translation reconstituted with purified components. Nat. Biotechnol. 19 (2001), 751–755.
179. [179] Yetisen, A.K., Akram, M.S., Lowe, C.R., Paper-based microfluidic point-of-care diagnostic devices. Lab Chip 13 (2013), 2210–2251.
180. [180] Ye, H., Charpin-El Hamri, G., Zwicky, K., Christen, M., Folcher, M., Fussenegger, M., Pharmaceutically controlled designer circuit for the treatment of the metabolic syndrome. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 141–146.
181. [181] Deacon, C.F., Plamboeck, A., Moller, S., Holst, J.J., GLP-1-(9-36) amide reduces blood glucose in anesthetized pigs by a mechanism that does not involve insulin secretion. Am. J. Physiol. Endocrinol. Metab. 282 (2002), E873–E879.
182. 2 transgene-control device. Mol. Cell 55 (2014), 397–408.
183. [183] Anderson, J.C., Clarke, E.J., Arkin, A.P., Voigt, C.A., Environmentally controlled invasion of cancer cells by engineered bacteria. J. Mol. Biol. 355 (2006), 619–627.
184. [184] Haellman, V., Fussenegger, M., Synthetic biology-toward therapeutic solutions. J. Mol. Biol., 2015.
185. [185] Giessen, T.W., Silver, P.A., Encapsulation as a strategy for the design of biological compartmentalization. J. Mol. Biol. 428 (2016), 916–927.
186. [186] Bugaj, L.J., Schaffer, D.V., Bringing next-generation therapeutics to the clinic through synthetic biology. Curr. Opin. Chem. Biol. 16 (2012), 355–361.
187. [187] Deans, T.L., Elisseeff, J.H., Stem cells in musculoskeletal engineered tissue. Curr. Opin. Biotechnol. 20 (2009), 537–544.
188. [188] Deans, T.L., Elisseeff, J.H., Mimicking Extracellular Matrix to Direct Stem Cell Differentiation. World Stem Cell Report, 2009, Genetics Policy Institute.
189. [189] Mazzitelli, S., Capretto, L., Quinci, F., Piva, R., Nastruzzi, C., Preparation of cell-encapsulation devices in confined microenvironment. Adv. Drug Deliv. Rev. 65 (2013), 1533–1555.
190. [190] Lathuiliere, A., Cosson, S., Lutolf, M.P., Schneider, B.L., Aebischer, P., A high-capacity cell macroencapsulation system supporting the long-term survival of genetically engineered allogeneic cells. Biomaterials 35 (2014), 779–791.
191. [191] Tavassoli, M., Crosby, W.H., Transplantation of marrow to extramedullary sites. Science 161 (1968), 54–56.
192. [192] Heathman, T.R., Nienow, A.W., McCall, M.J., Coopman, K., Kara, B., Hewitt, C.J., The translation of cell-based therapies: clinical landscape and manufacturing challenges. Regen. Med. 10 (2015), 49–64.
193. [193] Chamberlain, G., Fox, J., Ashton, B., Middleton, J., Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25 (2007), 2739–2749.
194. [194] Baraniak, P.R., McDevitt, T.C., Stem cell paracrine actions and tissue regeneration. Regen. Med. 5 (2010), 121–143.
195. [195] Murphy, M.B., Moncivais, K., Caplan, A.I., Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp. Mol. Med., 45, 2013, e54.
196. [196] Caplan, A.I., Correa, D., The MSC: an injury drugstore. Cell Stem Cell 9 (2011), 11–15.
197. [197] Morgan, R.A., Yang, J.C., Kitano, M., Dudley, M.E., Laurencot, C.M., Rosenberg, S.A., Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. Mol. Ther. 18 (2010), 843–851.
198. [198] Gill, S., Tasian, S.K., Ruella, M., Shestova, O., Li, Y., Porter, D.L., Carroll, M., Danet-Desnoyers, G., Scholler, J., Grupp, S.A., June, C.H., Kalos, M., Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells. Blood 123 (2014), 2343–2354.
199. [199] Grupp, S.A., Kalos, M., Barrett, D., Aplenc, R., Porter, D.L., Rheingold, S.R., Teachey, D.T., Chew, A., Hauck, B., Wright, J.F., Milone, M.C., Levine, B.L., June, C.H., Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N. Engl. J. Med. 368 (2013), 1509–1518.